Skip to main content

Table 2 Biochemical parameters at baseline (week 0) and end of treatment (week 12) with FTP or placebo in subjects with elevated ALT levels

From: The effectiveness of fermented turmeric powder in subjects with elevated alanine transaminase levels: a randomised controlled study

 

FTP group (n = 26)

Placebo group (n = 22)

P-value1)

Baseline

12 week

Baseline

12 week

ALT (IU/L)

     

Mean ± SD

61.1 ± 25.1

44.9 ± 15.5

55.7 ± 15.1

53.8 ± 26.3

0.019*

Median(Range)

51.5(41–151)

42.5(19–95)

49(40–85)

51(22–127)

-

AST (IU/L)

     

Mean ± SD

36.3 ± 13.8

27.9 ± 7.9

35.6 ± 8.8

34.8 ± 10.9

0.020*

Median(Range)

32.5(20–73)

27(17–46)

34(25–57)

33.5(21–55)

-

ALP (IU/L)

     

Mean ± SD

85.0 ± 19.3

80.0 ± 21.9

71.7 ± 13.5

68.9 ± 13.2

0.471

Median(Range)

81.5(52–144)

79(46–160)

69(48–101)

69(43–92)

-

gamma-GT (IU/L)

     

Mean ± SD

86.3 ± 71.5

66.9 ± 45.6

104.3 ± 69.0

100.8 ± 68.4

0.254

Median(Range)

64(26–360)

52(23–195)

95(16–231)

91(17–253)

-

Total bilirubin (mg/dL)

     

Mean ± SD

0.98 ± 0.46

0.88 ± 0.38

0.89 ± 0.28

0.84 ± 0.26

0.664

Median(Range)

0.87(0.37-2.29)

0.79(0.4-1.98)

0.9(0.37-1.37)

0.81(0.37-1.34)

-

  1. Values are presented as mean ± SD.
  2. 1. Linear mixed model for repeated measures data.
  3. * P <0.05.